203. Deputy Michael Healy-Rae asked the Minister for Health as the Health Products Regulatory Authority, adverse drug reaction reports for Roaccutane are unclear, for example, in 239 of 289 reports there is no indication why Roaccutane was used, if he will confirm the reason Roaccutane was used in these 239 cases; and if he will make a statement on the matter. [38693/15]

Summary

203. Deputy Michael Healy-Rae asked the Minister for Health as the Health Products Regulatory Authority, adverse drug reaction reports for Roaccutane are unclear, for example, in 239 of 289 reports there is no indication why Roaccutane was used, if he will confirm the reason Roaccutane was used in these 239 cases; and if he will make a statement on the matter. [38693/15]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Licensing

  xml · EN · 4 November 2015

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.